Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Clinical Trials Market Growing at 6.51% CAGR to 2030 Driven by Hybrid and Decentralized Trial Adoption | Mordor Intelligence Forecast

This image opens in the lightbox

News provided by

Mordor Intelligence Private Limited

28 Oct, 2025, 09:50 GMT

Share this article

Share toX

Share this article

Share toX

HYDERABAD, India, Oct. 28, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global clinical trials market is valued at USD 90.1 billion in 2025 and is projected to surpass USD 123.5 billion in 2030, growing at a 6.51% CAGR during the forecast period 2025-2030. The market growth is driven by the rising number of oncology studies, the shift toward decentralized and hybrid trial models, and continuous investment in digital trial infrastructure. The surge in chronic diseases and precision medicine initiatives is driving sponsors and research organizations to adopt more agile and data-driven clinical approaches.

Major Factors Shaping Market Dynamics

Rising Adoption of Decentralized and Hybrid Trial Models

Decentralized and hybrid trial models are transforming clinical research by reducing patient travel, improving retention, and expanding access through telehealth, local labs, and at-home monitoring. With growing acceptance among participants and clear regulatory guidance from the FDA, sponsors are focusing on technology readiness, data integrity, and cybersecurity as key priorities. This shift is also driving greater investment in digital platforms and reshaping how CROs deliver trial operations.

Integration of Advanced Analytics and AI

Sponsors increasingly use predictive analytics, AI-driven patient matching, and real-time trial monitoring to optimize enrollment, minimize delays, and improve protocol adherence.

Comprehensive Segmental Overview

By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design

  • Interventional / Treatment Studies
  • Observational Studies
  • Expanded Access Studies
  • By Service Type
  • Protocol Design & Feasibility
  • Site Identification & Start-up
  • Regulatory Submission & Approval
  • Clinical Trial Monitoring
  • Data Management & Biostatistics
  • Medical Writing
  • Other Service Types

By Therapeutic Area

  • Oncology
  • Cardiovascular
  • Neurology
  • Infectious Diseases
  • Metabolic Disorders (Diabetes, Obesity)
  • Immunology / Autoimmune
  • Other Therapeutic Areas

By Sponsor Type

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic & Research Institutes
  • Government & Non-profit Organizations

Regional Segment Insights

North America continues to hold a commanding position in the clinical trials market, backed by robust pharma-biotech investment, mature regulatory frameworks, and a dense network of CRO and site infrastructure. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, driven by expanding treatment-naïve populations, rising clinical-research capacity in China and India, and the growing appeal of cost-efficient, hybrid trial models in emerging geographies.

Geographical Coverage Includes:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report:
https://www.mordorintelligence.com/industry-reports/clinical-trials-market?utm_source=prnewswire

Strategic Market Landscape

The clinical trials market is moderately fragmented, with global CROs and service providers actively integrating digital-trial platforms, real-world-evidence modules, and decentralized capabilities into their portfolios. Strategic mergers, acquisitions, and long-term master services agreements are typical to secure end-to-end trial support.

Leading Clinical Trial Companies  

  • IQVIA Holdings Inc.
  • Laboratory Corporation of America (Labcorp)
  • ICON plc
  • Parexel International Corp.
  • Syneos Health

Check out related reports published by Mordor Intelligence:

Virtual Clinical Trials Market : The Virtual Clinical Trials Market Report is Segmented by Study Design (Interventional), Phase (Phase I, Component (Software Platforms and Services), Delivery Mode (Web-Based), End User (Medical-Device Manufacturers), Indication (Oncology), Geography (North America, Europe, Asia-Pacific).

Medable, IQVIA, Parexel International Corp, Labcorp (Covance) and ICON are the major companies operating in this market.

Read more about companies active in Virtual Clinical Trials: https://www.mordorintelligence.com/industry-reports/virtual-clinical-trials-market/companies?utm_source=prnewswire

Decentralized Clinical Trials Market: The Decentralized Clinical Trials Market Report is Segmented by Study Design (Interventional), Component (Cloud-Based Platforms), Therapeutic Application (Oncology, Cardiology), End-User (Pharmaceutical & Biotech Sponsors), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America).
https://www.mordorintelligence.com/industry-reports/decentralized-clinical-trials-market?utm_source=prnewswire

Clinical Trials Support Services Market : The Clinical Trial Support Services Market Report is Segmented by Phase (Phase I, Phase II), Service Types (Clinical Trial Site Management, Patient Recruitment & Retention), End User (Pharmaceutical Companies, Biotechnology Companies), Therapeutic Area (Oncology, Cardiology), and Geography (North America, Europe).

Roche, Eli Lilly and Company, Novo Nordisk, IQVIA and LabCorp are the major companies operating in this market.

Read more about companies active in Clinical Trials Support Services: https://www.mordorintelligence.com/industry-reports/clinical-trial-support-services-market/companies?utm_source=prnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

Modal title

Also from this source

Voluntary Carbon Credit Market - 50% CAGR for 2025-2030 Driven by Expanding Corporate Net-Zero Commitments, Reports Mordor Intelligence

Voluntary Carbon Credit Market - 50% CAGR for 2025-2030 Driven by Expanding Corporate Net-Zero Commitments, Reports Mordor Intelligence

According to the latest insights from Mordor Intelligence, the voluntary carbon credit market size is valued at USD 15.83 billion in 2025 and is...

Low-Code Development Platform Market Worth $67Bn by 2030 & growing at over 20% CAGR as AI & Cloud Adoption Keep Rising: Mordor Intelligence

Low-Code Development Platform Market Worth $67Bn by 2030 & growing at over 20% CAGR as AI & Cloud Adoption Keep Rising: Mordor Intelligence

According to the latest analysis by Mordor Intelligence, the low-code development platform market is valued at USD 26.30 billion in 2025 and is...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Publishing & Information Services

Publishing & Information Services

Computer & Electronics

Computer & Electronics

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.